Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
A-prexa vs Zyprexa in Schizophrenia and Related Disorders
NCT02137993Phase 4Completed
- Sponsor
- HK inno.N Corporation
- Start
- Mar 2012
- Primary completion
- May 2013
- Modality
- Small Molecules
01
Overview
Phase 4, randomised, double-blind trial of olanzapine in schizophrenia, schizophreniform disorder and schizoaffective disorder, sponsored by HK inno.N Corporation. Primary endpoint: Positive and Negative Syndrome Scale at 6 weeks. Started Mar 2012; status: completed.
02
Drugs
olanzapine
03
Conditions
schizophreniaschizophreniform disorderschizoaffective disorder
Beyond the preview
Go deeper on NCT02137993.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02137993.